2024
Safety of naltrexone in patients with cirrhosis
Thompson R, Taddei T, Kaplan D, Rabiee A. Safety of naltrexone in patients with cirrhosis. JHEP Reports 2024, 6: 101095. PMID: 38961852, PMCID: PMC11220533, DOI: 10.1016/j.jhepr.2024.101095.Peer-Reviewed Original ResearchDrug-induced liver injuryRoussel Uclaf Causality Assessment MethodAlcohol use disorderInitiation of naltrexoneSafety of naltrexoneUse disorderRetrospective studyDevelopment of drug-induced liver injuryRoussel Uclaf Causality Assessment Method scoreLiver injuryLiver diseaseRetrospective study of patientsTreatment of alcohol use disordersTreat alcohol use disorderLiver enzyme elevationAlcohol-related cirrhosisCohort of patientsAlkaline phosphatase elevationDiagnosis of cirrhosisStudy of patientsAssociated with developmentCausality Assessment MethodPrescribed naltrexoneDecompensated cirrhosisEnzyme elevationKeep beta-blocking and carry on!
Rabiee A, Rabiee A. Keep beta-blocking and carry on! Clinical Liver Disease 2024, 23: e0114. PMID: 38304323, PMCID: PMC10833629, DOI: 10.1097/cld.0000000000000114.Peer-Reviewed Original Research
2023
Interventional Radiology and Surgical Treatment Options for Non-Cirrhotic Portal Hypertension
Rabiee A, Cornman-Homonoff J, Kunstman J, Garcia-Tsao G, Taddei T. Interventional Radiology and Surgical Treatment Options for Non-Cirrhotic Portal Hypertension. Current Hepatology Reports 2023, 22: 269-275. DOI: 10.1007/s11901-023-00617-4.Peer-Reviewed Original ResearchPortal hypertensionInterventional radiologyNon-cirrhotic portal hypertensionPorto-sinusoidal vascular diseaseHepatic sinusoidal obstruction syndromeAbsence of cirrhosisPortal vein thrombosisSinusoidal obstruction syndromeBudd-Chiari syndromeSurgical treatment optionsHepatic vascular anatomyObstruction syndromeVein thrombosisSurgical treatmentTreatment optionsVascular diseaseImproved outcomesTherapeutic evaluationVascular anatomyHeterogenous groupHypertensionSyndromeDisordersOutcomesTreatmentBrief overview of immunosuppression and its side effects after liver transplantation
Rabiee A, Girone G, Davis J. Brief overview of immunosuppression and its side effects after liver transplantation. Clinical Liver Disease 2023, 21: 160-164. PMID: 37937047, PMCID: PMC10627593, DOI: 10.1097/cld.0000000000000035.Peer-Reviewed Original ResearchMedications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
Rabiee A, Mahmud N, Falker C, Garcia-Tsao G, Taddei T, Kaplan D. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis. Hepatology Communications 2023, 7: e0093. PMID: 36972386, PMCID: PMC10043587, DOI: 10.1097/hc9.0000000000000093.Peer-Reviewed Original ResearchConceptsAlcohol-associated cirrhosisAlcohol use disorderUse disordersCause mortalityImproved survivalPropensity scoreInpatient diagnosis codesRetrospective cohort studyCox regression analysisActive alcohol useCirrhosis decompensationCohort studyConcurrent diagnosisLiver diseasePotential confoundersDiagnosis codesVeteran outcomesCirrhosis diagnosisStrong negative predictorCirrhosisPatientsHazardous drinkingAlcohol use behaviorsCosts AssociatedAlcohol use
2022
Simplifying the Diagnosis and Treatment of Hepatitis B Infection: One Step for Addressing Deficits in the Care Cascade, One Leap for Elimination
Rabiee A, Lim J. Simplifying the Diagnosis and Treatment of Hepatitis B Infection: One Step for Addressing Deficits in the Care Cascade, One Leap for Elimination. Gastro Hep Advances 2022, 2: 277-278. PMID: 39132614, PMCID: PMC11307652, DOI: 10.1016/j.gastha.2022.12.002.Commentaries, Editorials and LettersNoninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model
Rabiee A, Deng Y, Ciarleglio M, Chan JL, Pons M, Genesca J, Garcia‐Tsao G. Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model. Hepatology Communications 2022, 6: 3324-3334. PMID: 36214066, PMCID: PMC9701481, DOI: 10.1002/hep4.2091.Peer-Reviewed Original ResearchConceptsHepatic venous pressure gradientSignificant portal hypertensionTransient elastographyNASH cirrhosisPortal hypertensionFibrosis-4 indexPresence of CSPHVenous pressure gradientNonalcoholic steatohepatitis cirrhosisBody mass indexLiver stiffness measurementGood calibrationCompensated cirrhosisFIB-4Mass indexPlatelet countValidation cohortNoninvasive predictorTraining cohortBaseline riskLaboratory valuesCirrhosisHigh riskSeparate cohortNoninvasive surrogateNonselective Beta‐Blockers in Portal Hypertension: Why, When, and How?
Rabiee A, Garcia‐Tsao G, Tapper EB. Nonselective Beta‐Blockers in Portal Hypertension: Why, When, and How? Clinical Liver Disease 2022, 19: 118-123. PMID: 35355838, PMCID: PMC8958249, DOI: 10.1002/cld.1182.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis
Alrabadi LS, Dutton A, Rabiee A, Roberts SJ, Deng Y, Cusack L, Silveira MG, Ciarleglio M, Bucala R, Sinha R, Boyer JL, Assis DN. Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis. JHEP Reports 2022, 4: 100450. PMID: 35434588, PMCID: PMC9011026, DOI: 10.1016/j.jhepr.2022.100450.Peer-Reviewed Original ResearchQuality of lifeMindfulness-based stress reductionInflammatory cytokine levelsDisease activityCytokine levelsAutoimmune hepatitisAlanine aminotransferaseAdult patientsTRIAL REGISTRATIONPeripheral blood cytokine levelsScore improvementMBSR programPilot studyBlood cytokine levelsSerum alanine aminotransferaseClinical trial registrationSignificant dose reductionPerceived stressExploratory pilot studyALT levelsSteroid requirementsStress reductionCytokine mediatorsALT reductionMedication needs
2021
Changes in Ascitic Fluid Polymorphonuclear Cell Count After Antibiotics Are Associated With Mortality in Spontaneous Bacterial Peritonitis
Saffo S, To UK, Santoiemma PP, Laurito M, Haque L, Rabiee A, Verna EC, Angarone MP, Garcia-Tsao G. Changes in Ascitic Fluid Polymorphonuclear Cell Count After Antibiotics Are Associated With Mortality in Spontaneous Bacterial Peritonitis. Clinical Gastroenterology And Hepatology 2021, 20: e1201-e1204. PMID: 34273564, PMCID: PMC11090177, DOI: 10.1016/j.cgh.2021.07.019.Peer-Reviewed Original ResearchPrimary sclerosing cholangitis
Rabiee A, Silveira MG. Primary sclerosing cholangitis. Translational Gastroenterology And Hepatology 2021, 6: 29-29. PMID: 33824933, PMCID: PMC7829069, DOI: 10.21037/tgh-20-266.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsInflammatory bowel diseaseLiver transplantationDominant stricturesRare chronic cholestatic liver diseaseChronic cholestatic liver diseaseEnd-stage PSCEtiology of PSCManagement of PSCCommon presenting symptomAbnormal immune responseCumulative lifetime riskEffective medical therapyExtrahepatic bile ductCholestatic liver diseaseTreatment of symptomsScreening of patientsBacterial cholangitisEligible patientsLT indicationAbdominal painPresenting symptomColorectal malignancyInflammatory destructionProgressive diseaseBile stasis
2020
Factors associated with health‐related quality of life in patients with cirrhosis: a systematic review
Rabiee A, Ximenes R, Nikayin S, Hickner A, Juthani P, Rosen RH, Garcia‐Tsao G. Factors associated with health‐related quality of life in patients with cirrhosis: a systematic review. Liver International 2020, 41: 6-15. PMID: 32998172, DOI: 10.1111/liv.14680.Peer-Reviewed Original ResearchConceptsHealth-related qualityPoor HRQOLMuscle crampsHepatic encephalopathyPoor sleepSystematic reviewPoor health-related qualityPatient-reported outcomesPoor social supportPatient-centered careFull-text screeningAdult patientsPoor HRQoL.Cirrhosis etiologyHRQoLCirrhosisGeneric instrumentsEligibility criteriaCognitive impairmentPatientsMajority of studiesIdentified factorsCrampsDemographic factorsFrailty
2019
Six-Minute Walk Distance After Critical Illness: A Systematic Review and Meta-Analysis
Parry SM, Nalamalapu SR, Nunna K, Rabiee A, Friedman LA, Colantuoni E, Needham DM, Dinglas VD. Six-Minute Walk Distance After Critical Illness: A Systematic Review and Meta-Analysis. Journal Of Intensive Care Medicine 2019, 36: 343-351. PMID: 31690160, PMCID: PMC7442114, DOI: 10.1177/0885066619885838.Peer-Reviewed Original ResearchConceptsAcute respiratory distress syndromeICU-related variablesCritical illnessWalk distanceFemale sexSystematic reviewIntensive care unit admissionSix-minute walk distanceICU-related factorsCare unit admissionRespiratory distress syndromeImpaired physical functioningRandom-effects modelClinical research studiesUnit admissionHospital dischargeDistress syndromeWalk testPhysical functioningLast searchPost dischargeFunctional capacityPatient statusEligible articlesARDS status
2017
Evaluation of a strategy for enrolling the families of critically ill patients in research using limited human resources
Turnbull AE, Hashem MD, Rabiee A, To A, Chessare CM, Needham DM. Evaluation of a strategy for enrolling the families of critically ill patients in research using limited human resources. PLOS ONE 2017, 12: e0177741. PMID: 28542632, PMCID: PMC5444627, DOI: 10.1371/journal.pone.0177741.Peer-Reviewed Original ResearchConceptsEligible patientsConsent ratesHealthcare proxyIntensive care unit patientsFamily membersLonger ICU stayCare unit patientsFamilies of patientsEligible family membersICU stayPrimary outcomeSecondary outcomesUnit patientsIll patientsClinical trialsPatientsEnrollment periodFamily presenceEligible familiesICUConsecutive daysSuccess rateZip codesWeeksImportant demographic differencesMeasuring Patient Mobility in the ICU Using a Novel Noninvasive Sensor
J. A, Rawat N, Reiter A, Shrock C, Zhan A, Stone A, Rabiee A, Griffin S, Needham DM, Saria S. Measuring Patient Mobility in the ICU Using a Novel Noninvasive Sensor. Critical Care Medicine 2017, 45: 630-636. PMID: 28291092, PMCID: PMC5697716, DOI: 10.1097/ccm.0000000000002265.Peer-Reviewed Original Research
2016
A systematic review finds limited data on measurement properties of instruments measuring outcomes in adult intensive care unit survivors
Robinson KA, Davis WE, Dinglas VD, Mendez-Tellez PA, Rabiee A, Sukrithan V, Yalamanchilli R, Turnbull AE, Needham DM. A systematic review finds limited data on measurement properties of instruments measuring outcomes in adult intensive care unit survivors. Journal Of Clinical Epidemiology 2016, 82: 37-46. PMID: 27865899, PMCID: PMC5325798, DOI: 10.1016/j.jclinepi.2016.08.014.Peer-Reviewed Original ResearchConceptsAdult intensive care unit survivorsIntensive care unit survivorsAdult ICU survivorsICU survivorsEligible studiesHRQOL outcomesMental healthMeasurement propertiesCOSMIN checklistSystematic reviewHealth-related qualityAllied Health LiteratureQuality of lifeRelevant review articlesNumber of studiesCritical illnessCochrane LibraryCumulative IndexReference listsHealth LiteratureManual searchLife outcomesSurvivorsOutcomesFair qualityDepressive Symptoms After Critical Illness
Rabiee A, Nikayin S, Hashem MD, Huang M, Dinglas VD, Bienvenu OJ, Turnbull AE, Needham DM. Depressive Symptoms After Critical Illness. Critical Care Medicine 2016, 44: 1744-1753. PMID: 27153046, PMCID: PMC7418220, DOI: 10.1097/ccm.0000000000001811.Peer-Reviewed Original ResearchConceptsDepressive symptomsICU survivorsHospital AnxietyRisk factorsCochrane Controlled Trials RegistryDepression Scale depression subscaleImportant depressive symptomsControlled Trials RegistryDuplicate independent reviewAllied Health LiteratureCritical illnessHospital dischargeTrials RegistryPsychologic morbidityPooled changeCumulative IndexEligible articlesHealth LiteratureSymptomsNatural historyDistress symptomsPrevalenceThreshold scoreTime pointsMonthsAnxiety symptoms in survivors of critical illness: a systematic review and meta-analysis
Nikayin S, Rabiee A, Hashem MD, Huang M, Bienvenu OJ, Turnbull AE, Needham DM. Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis. General Hospital Psychiatry 2016, 43: 23-29. PMID: 27796253, PMCID: PMC5289740, DOI: 10.1016/j.genhosppsych.2016.08.005.Peer-Reviewed Original ResearchConceptsICU survivorsCritical illnessAnxiety symptomsPsychiatric symptomsPhysical rehabilitationDepression Scale-Anxiety subscaleSeverity of illnessAdult ICU survivorsLength of stayPotential risk factorsAnxiety symptom prevalenceSubset of studiesSymptom prevalenceHospital AnxietyRisk factorsICU diariesMerit further investigationSame patientDelusional experiencesSystematic reviewSymptomsAnxiety scoresIllnessSurvivorsAdmissionOutcome Measurement in ICU Survivorship Research From 1970 to 2013
Turnbull AE, Rabiee A, Davis WE, Nasser MF, Venna VR, Lolitha R, Hopkins RO, Bienvenu OJ, Robinson KA, Needham DM. Outcome Measurement in ICU Survivorship Research From 1970 to 2013. Critical Care Medicine 2016, 44: 1267-1277. PMID: 26992067, PMCID: PMC4911315, DOI: 10.1097/ccm.0000000000001651.Peer-Reviewed Original ResearchConceptsQuality of lifeICU survivorsCohort studyParticipation restrictionsCritical illnessActivity limitationsCore outcomeInternational ClassificationEligible articlesLife outcomesMental healthPhysical activity limitationsCritical illness survivorsWorld Health Organization's International ClassificationCross-sectional studyPatient-reported measuresMental health impairmentEvidence of consolidationMedian sample sizeHospital dischargeFuture trialsPatient outcomesSurvivorship researchOutcome measurementsPeer-reviewed publications
2013
Seroprevalence of Hepatitis A among Students Enrolled in Tehran University of Medical Sciences during 2011.
Rabiee A, Nikayin S, Hashemi SR, Mohaghegh M, Amini M, Rabiee R, Merat S. Seroprevalence of Hepatitis A among Students Enrolled in Tehran University of Medical Sciences during 2011. Middle East Journal Of Digestive Diseases 2013, 5: 137-40. PMID: 24829683, PMCID: PMC3990182.Peer-Reviewed Original ResearchHepatitis A virusHepatitis ATehran UniversitySeroprevalence of HAVAnti-HAV IgG antibodiesAnti-HAV antibodiesHealth science studentsHigh-risk groupUniversal vaccination strategyMedical SciencesIgG antibodiesVaccination strategiesRisk groupsHealth workersTargeted vaccinationHigh riskGeneral populationSeropositive resultsA virusSimple questionnaireSerum samplesSeroprevalenceVaccinationSerious diseasePrevious reports